Advancing the field: evidence for new management strategies in invasive fungal infections

Research output: Contribution to journalArticleOther

11 Citations (Scopus)

Abstract

Invasive fungal infections (IFI) are a significant cause of morbidity and mortality in the immunocompromised. The traditional diagnostic methods of culture and histological examination lack sensitivity and often only make a diagnosis late when the fungal burden is high, reducing the chances of cure even with the availability of new more potent and less toxic antifungal agents. New non-culture-based serological and PCR assays have been developed. These appear more sensitive and are able to make an earlier diagnosis as compared with traditional diagnostic methods. Early diagnosis is central to reducing IFI-related morbidity and mortality. This review describes the diagnostic potential of the new serological and PCR assays and outlines how these assays have been incorporated into algorithms to improve the management of IFI. ? 2013 The Author(s).
Original languageEnglish
Pages (from-to)51 - 58
Number of pages8
JournalCurrent Fungal Infection Reports
Volume7
Issue number1
DOIs
Publication statusPublished - 2013

Cite this

@article{3c05393168554c758d447089d0a10fa2,
title = "Advancing the field: evidence for new management strategies in invasive fungal infections",
abstract = "Invasive fungal infections (IFI) are a significant cause of morbidity and mortality in the immunocompromised. The traditional diagnostic methods of culture and histological examination lack sensitivity and often only make a diagnosis late when the fungal burden is high, reducing the chances of cure even with the availability of new more potent and less toxic antifungal agents. New non-culture-based serological and PCR assays have been developed. These appear more sensitive and are able to make an earlier diagnosis as compared with traditional diagnostic methods. Early diagnosis is central to reducing IFI-related morbidity and mortality. This review describes the diagnostic potential of the new serological and PCR assays and outlines how these assays have been incorporated into algorithms to improve the management of IFI. ? 2013 The Author(s).",
author = "Orla Morrissey",
year = "2013",
doi = "10.1007/s12281-012-0128-4",
language = "English",
volume = "7",
pages = "51 -- 58",
journal = "Current Fungal Infection Reports",
issn = "1936-3761",
publisher = "Springer-Verlag London Ltd.",
number = "1",

}

Advancing the field: evidence for new management strategies in invasive fungal infections. / Morrissey, Orla.

In: Current Fungal Infection Reports, Vol. 7, No. 1, 2013, p. 51 - 58.

Research output: Contribution to journalArticleOther

TY - JOUR

T1 - Advancing the field: evidence for new management strategies in invasive fungal infections

AU - Morrissey, Orla

PY - 2013

Y1 - 2013

N2 - Invasive fungal infections (IFI) are a significant cause of morbidity and mortality in the immunocompromised. The traditional diagnostic methods of culture and histological examination lack sensitivity and often only make a diagnosis late when the fungal burden is high, reducing the chances of cure even with the availability of new more potent and less toxic antifungal agents. New non-culture-based serological and PCR assays have been developed. These appear more sensitive and are able to make an earlier diagnosis as compared with traditional diagnostic methods. Early diagnosis is central to reducing IFI-related morbidity and mortality. This review describes the diagnostic potential of the new serological and PCR assays and outlines how these assays have been incorporated into algorithms to improve the management of IFI. ? 2013 The Author(s).

AB - Invasive fungal infections (IFI) are a significant cause of morbidity and mortality in the immunocompromised. The traditional diagnostic methods of culture and histological examination lack sensitivity and often only make a diagnosis late when the fungal burden is high, reducing the chances of cure even with the availability of new more potent and less toxic antifungal agents. New non-culture-based serological and PCR assays have been developed. These appear more sensitive and are able to make an earlier diagnosis as compared with traditional diagnostic methods. Early diagnosis is central to reducing IFI-related morbidity and mortality. This review describes the diagnostic potential of the new serological and PCR assays and outlines how these assays have been incorporated into algorithms to improve the management of IFI. ? 2013 The Author(s).

UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568482/pdf/12281_2012_Article_128.pdf

U2 - 10.1007/s12281-012-0128-4

DO - 10.1007/s12281-012-0128-4

M3 - Article

VL - 7

SP - 51

EP - 58

JO - Current Fungal Infection Reports

JF - Current Fungal Infection Reports

SN - 1936-3761

IS - 1

ER -